La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels.

Identifieur interne : 001638 ( Main/Exploration ); précédent : 001637; suivant : 001639

Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels.

Auteurs : Moonhee Lee [Canada] ; Nattinee Jantaratnotai ; Edith Mcgeer ; James G. Mclarnon ; Patrick L. Mcgeer

Source :

RBID : pubmed:21040713

English descriptors

Abstract

Mg(2+) is a known antagonist of some Ca(2+) ion channels. It may therefore be able to counteract the toxic consequences of excessive Ca(2+) entry into immune-type cells. Here we examined the effects of Mg(2+) on inflammation induced by Ca(2+) influx into microglia and THP-1 cells following activation of purinergic receptors. Using tissue culture, an inflammatory response was induced by treatment with either the P2X7 purinergic receptor agonist 2',3'-[benzoyl-4-benzoyl]-ATP (BzATP) or the P2Y2,4 receptor agonist uridine 5'-triphosphate (UTP). Both microglia and THP-1 cells expressed the mRNAs for these receptors. Treatment produced a rapid rise in intracellular Ca(2+) which was significantly reduced by Mg(2+) or the calcium chelator BAPTA-AM. Purinergic receptor stimulation activated the intracellular inflammatory pathway P38 MAP kinase and NFκB. This caused release of TNFα, IL-6, nitrite ions and other materials that are neurotoxic to SH-SY5Y cells. These effects were all ameliorated by Mg(2+). They were also partly ameliorated by the P2X7R antagonists, oxATP and KN-62, the P2YR antagonist MRS2179, and the store operated Ca(2+) channel blocker, SK96365. These results indicate that elevated Mg(2+) is a broad spectrum inhibitor of Ca(2+) entry into microglia or THP-1 cells. Mg(2+) administration may be a strategy for reducing the damaging consequences Ca(2+) induced neuroinflammation in degenerative neurological disorders such as Alzheimer disease and Parkinson disease.

DOI: 10.1016/j.brainres.2010.10.084
PubMed: 21040713


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels.</title>
<author>
<name sortKey="Lee, Moonhee" sort="Lee, Moonhee" uniqKey="Lee M" first="Moonhee" last="Lee">Moonhee Lee</name>
<affiliation wicri:level="1">
<nlm:affiliation>Kinsmen Laboratory of Neurological Research, 2255 Wesbrook Mall, University of British Columbia, Vancouver, BC, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Kinsmen Laboratory of Neurological Research, 2255 Wesbrook Mall, University of British Columbia, Vancouver, BC</wicri:regionArea>
<wicri:noRegion>BC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Jantaratnotai, Nattinee" sort="Jantaratnotai, Nattinee" uniqKey="Jantaratnotai N" first="Nattinee" last="Jantaratnotai">Nattinee Jantaratnotai</name>
</author>
<author>
<name sortKey="Mcgeer, Edith" sort="Mcgeer, Edith" uniqKey="Mcgeer E" first="Edith" last="Mcgeer">Edith Mcgeer</name>
</author>
<author>
<name sortKey="Mclarnon, James G" sort="Mclarnon, James G" uniqKey="Mclarnon J" first="James G" last="Mclarnon">James G. Mclarnon</name>
</author>
<author>
<name sortKey="Mcgeer, Patrick L" sort="Mcgeer, Patrick L" uniqKey="Mcgeer P" first="Patrick L" last="Mcgeer">Patrick L. Mcgeer</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21040713</idno>
<idno type="pmid">21040713</idno>
<idno type="doi">10.1016/j.brainres.2010.10.084</idno>
<idno type="wicri:Area/PubMed/Corpus">000C53</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C53</idno>
<idno type="wicri:Area/PubMed/Curation">000C53</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000C53</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000C53</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000C53</idno>
<idno type="wicri:Area/Ncbi/Merge">000D68</idno>
<idno type="wicri:Area/Ncbi/Curation">000D68</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000D68</idno>
<idno type="wicri:Area/Main/Merge">001706</idno>
<idno type="wicri:Area/Main/Curation">001638</idno>
<idno type="wicri:Area/Main/Exploration">001638</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels.</title>
<author>
<name sortKey="Lee, Moonhee" sort="Lee, Moonhee" uniqKey="Lee M" first="Moonhee" last="Lee">Moonhee Lee</name>
<affiliation wicri:level="1">
<nlm:affiliation>Kinsmen Laboratory of Neurological Research, 2255 Wesbrook Mall, University of British Columbia, Vancouver, BC, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Kinsmen Laboratory of Neurological Research, 2255 Wesbrook Mall, University of British Columbia, Vancouver, BC</wicri:regionArea>
<wicri:noRegion>BC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Jantaratnotai, Nattinee" sort="Jantaratnotai, Nattinee" uniqKey="Jantaratnotai N" first="Nattinee" last="Jantaratnotai">Nattinee Jantaratnotai</name>
</author>
<author>
<name sortKey="Mcgeer, Edith" sort="Mcgeer, Edith" uniqKey="Mcgeer E" first="Edith" last="Mcgeer">Edith Mcgeer</name>
</author>
<author>
<name sortKey="Mclarnon, James G" sort="Mclarnon, James G" uniqKey="Mclarnon J" first="James G" last="Mclarnon">James G. Mclarnon</name>
</author>
<author>
<name sortKey="Mcgeer, Patrick L" sort="Mcgeer, Patrick L" uniqKey="Mcgeer P" first="Patrick L" last="Mcgeer">Patrick L. Mcgeer</name>
</author>
</analytic>
<series>
<title level="j">Brain research</title>
<idno type="eISSN">1872-6240</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Blotting, Western</term>
<term>Calcium (metabolism)</term>
<term>Cell Line</term>
<term>Humans</term>
<term>Inflammation (metabolism)</term>
<term>Inflammation (pathology)</term>
<term>Inflammation (physiopathology)</term>
<term>Interleukin-6 (biosynthesis)</term>
<term>Ions (metabolism)</term>
<term>Magnesium (metabolism)</term>
<term>Microglia (drug effects)</term>
<term>Microglia (metabolism)</term>
<term>Microglia (pathology)</term>
<term>Purinergic Agonists (pharmacology)</term>
<term>Receptors, Purinergic P2 (metabolism)</term>
<term>Receptors, Purinergic P2X7 (metabolism)</term>
<term>Receptors, Purinergic P2Y2 (metabolism)</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Signal Transduction (physiology)</term>
<term>Tumor Necrosis Factor-alpha (biosynthesis)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en">
<term>Interleukin-6</term>
<term>Tumor Necrosis Factor-alpha</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Calcium</term>
<term>Ions</term>
<term>Magnesium</term>
<term>Receptors, Purinergic P2</term>
<term>Receptors, Purinergic P2X7</term>
<term>Receptors, Purinergic P2Y2</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Microglia</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Inflammation</term>
<term>Microglia</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Inflammation</term>
<term>Microglia</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Purinergic Agonists</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Signal Transduction</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en">
<term>Inflammation</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Blotting, Western</term>
<term>Cell Line</term>
<term>Humans</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Mg(2+) is a known antagonist of some Ca(2+) ion channels. It may therefore be able to counteract the toxic consequences of excessive Ca(2+) entry into immune-type cells. Here we examined the effects of Mg(2+) on inflammation induced by Ca(2+) influx into microglia and THP-1 cells following activation of purinergic receptors. Using tissue culture, an inflammatory response was induced by treatment with either the P2X7 purinergic receptor agonist 2',3'-[benzoyl-4-benzoyl]-ATP (BzATP) or the P2Y2,4 receptor agonist uridine 5'-triphosphate (UTP). Both microglia and THP-1 cells expressed the mRNAs for these receptors. Treatment produced a rapid rise in intracellular Ca(2+) which was significantly reduced by Mg(2+) or the calcium chelator BAPTA-AM. Purinergic receptor stimulation activated the intracellular inflammatory pathway P38 MAP kinase and NFκB. This caused release of TNFα, IL-6, nitrite ions and other materials that are neurotoxic to SH-SY5Y cells. These effects were all ameliorated by Mg(2+). They were also partly ameliorated by the P2X7R antagonists, oxATP and KN-62, the P2YR antagonist MRS2179, and the store operated Ca(2+) channel blocker, SK96365. These results indicate that elevated Mg(2+) is a broad spectrum inhibitor of Ca(2+) entry into microglia or THP-1 cells. Mg(2+) administration may be a strategy for reducing the damaging consequences Ca(2+) induced neuroinflammation in degenerative neurological disorders such as Alzheimer disease and Parkinson disease.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Jantaratnotai, Nattinee" sort="Jantaratnotai, Nattinee" uniqKey="Jantaratnotai N" first="Nattinee" last="Jantaratnotai">Nattinee Jantaratnotai</name>
<name sortKey="Mcgeer, Edith" sort="Mcgeer, Edith" uniqKey="Mcgeer E" first="Edith" last="Mcgeer">Edith Mcgeer</name>
<name sortKey="Mcgeer, Patrick L" sort="Mcgeer, Patrick L" uniqKey="Mcgeer P" first="Patrick L" last="Mcgeer">Patrick L. Mcgeer</name>
<name sortKey="Mclarnon, James G" sort="Mclarnon, James G" uniqKey="Mclarnon J" first="James G" last="Mclarnon">James G. Mclarnon</name>
</noCountry>
<country name="Canada">
<noRegion>
<name sortKey="Lee, Moonhee" sort="Lee, Moonhee" uniqKey="Lee M" first="Moonhee" last="Lee">Moonhee Lee</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001638 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001638 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21040713
   |texte=   Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21040713" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonCanadaV1 

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022